Literature DB >> 18566915

Major contribution from recurrent alterations and MSH6 mutations in the Danish Lynch syndrome population.

Mef Nilbert1, Friedrik P Wikman, Thomas V O Hansen, Henrik B Krarup, Torben F Orntoft, Finn C Nielsen, Lone Sunde, Anne-Marie Gerdes, Dorthe Cruger, Susanne Timshel, Marie-Louise Bisgaard, Inge Bernstein, Henrik Okkels.   

Abstract

An increasing number of mismatch-repair (MMR) gene mutations have been identified in hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome. This study presents the population-based Danish MMR gene mutation profile, which contains 138 different MMR gene alterations. Among these, 88 mutations in 164 families are considered pathogenic and an additional 50 variants from 76 families are considered to represent variants of unknown pathogenicity. The different MMR genes contribute to 40% (MSH2), 29% (MLH1), and 22% (MSH6) of the mutations and the Danish population thus shows a considerably higher frequency of MSH6 mutations than previously described. Although 69/88 (78%) pathogenic mutations were present in a single family, previously recognized recurrent/founder mutations were causative in 75/137 (55%) MLH1/MSH2 mutant families. In addition, the Danish MLH1 founder mutation c.1667+2_1667_+8TAAATCAdelinsATTT was identified in 14/58 (24%) MLH1 mutant families. The Danish Lynch syndrome population thus demonstrates that MSH6 mutations and recurrent/founder mutations have a larger contribution than previously recognized, which implies that the MSH6 gene should be included in routine diagnostics and suggests that directed analysis of recurrent/founder mutations may be feasible e.g. in families were diagnostic material is restricted to archival tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566915     DOI: 10.1007/s10689-008-9199-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  33 in total

1.  Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein.

Authors:  Saara Ollila; Laura Sarantaus; Reetta Kariola; Philip Chan; Heather Hampel; Elke Holinski-Feder; Finlay Macrae; Maija Kohonen-Corish; Anne-Marie Gerdes; Päivi Peltomäki; Elisabeth Mangold; Albert de la Chapelle; Marc Greenblatt; Minna Nyström
Journal:  Gastroenterology       Date:  2006-08-22       Impact factor: 22.682

2.  Recurrent germline mutation in MSH2 arises frequently de novo.

Authors:  D C Desai; J C Lockman; R B Chadwick; X Gao; A Percesepe; D G Evans; M Miyaki; S T Yuen; P Radice; E R Maher; F A Wright; A de La Chapelle
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

3.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.

Authors:  W D Foulkes; I Thiffault; S B Gruber; M Horwitz; N Hamel; C Lee; J Shia; A Markowitz; A Figer; E Friedman; D Farber; C M T Greenwood; J D Bonner; K Nafa; T Walsh; V Marcus; L Tomsho; J Gebert; F A Macrae; C L Gaff; B Bressac-De Paillerets; P K Gregersen; J N Weitzel; P H Gordon; E MacNamara; M-C King; H Hampel; A De La Chapelle; J Boyd; K Offit; G Rennert; G Chong; N A Ellis
Journal:  Am J Hum Genet       Date:  2002-11-26       Impact factor: 11.025

5.  Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families.

Authors:  Monika Grabowski; Yvonne Mueller-Koch; Eva Grasbon-Frodl; Udo Koehler; Gisela Keller; Holger Vogelsang; Wolfgang Dietmaier; Reinhard Kopp; Ulrike Siebers; Wolfgang Schmitt; Birgit Neitzel; Maria Gruber; Christa Doerner; Brigitte Kerker; Petra Ruemmele; Gabriele Henke; Elke Holinski-Feder
Journal:  Genet Test       Date:  2005

6.  Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.

Authors:  Kristina Lagerstedt Robinson; Tao Liu; Jana Vandrovcova; Britta Halvarsson; Mark Clendenning; Thierry Frebourg; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Päivi Peltomäki; Richard D Kolodner; Mef Nilbert; Annika Lindblom
Journal:  J Natl Cancer Inst       Date:  2007-02-21       Impact factor: 13.506

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Authors:  Yvonne M C Hendriks; Anja Wagner; Hans Morreau; Fred Menko; Astrid Stormorken; Franz Quehenberger; Lodewijk Sandkuijl; Pal Møller; Maurizio Genuardi; Hans Van Houwelingen; Carli Tops; Marjo Van Puijenbroek; Paul Verkuijlen; Gemma Kenter; Anneke Van Mil; Hanne Meijers-Heijboer; Gita B Tan; Martijn H Breuning; Riccardo Fodde; Juul Th Wijnen; Annette H J T Bröcker-Vriends; Hans Vasen
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

9.  Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

Authors:  F S Leach; N C Nicolaides; N Papadopoulos; B Liu; J Jen; R Parsons; P Peltomäki; P Sistonen; L A Aaltonen; M Nyström-Lahti
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

10.  A new variant database for mismatch repair genes associated with Lynch syndrome.

Authors:  Michael O Woods; Phillip Williams; Amanda Careen; Laura Edwards; Sylvia Bartlett; John R McLaughlin; H Banfield Younghusband
Journal:  Hum Mutat       Date:  2007-07       Impact factor: 4.878

View more
  21 in total

1.  Lynch Syndrome in high risk Ashkenazi Jews in Israel.

Authors:  Yael Goldberg; Inbal Kedar; Revital Kariiv; Naama Halpern; Morasha Plesser; Ayala Hubert; Luna Kaduri; Michal Sagi; Israela Lerer; Dvorah Abeliovich; Tamar Hamburger; Aviram Nissan; Hanoch Goldshmidt; Irit Solar; Ravit Geva; Hana Strul; Guy Rosner; Hagit Baris; Zohar Levi; Tamar Peretz
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

2.  Unsolicited information letters to increase awareness of Lynch syndrome and familial colorectal cancer: reactions and attitudes.

Authors:  Helle Vendel Petersen; Birgitte Lidegaard Frederiksen; Charlotte Kvist Lautrup; Lars Joachim Lindberg; Steen Ladelund; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-01       Impact factor: 2.375

3.  Functional characterization of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients.

Authors:  Lise Lotte Christensen; Reetta Kariola; Mari K Korhonen; Friedrik P Wikman; Lone Sunde; Anne-Marie Gerdes; Henrik Okkels; Carsten A Brandt; Inge Bernstein; Thomas V O Hansen; Rikke Hagemann-Madsen; Claus L Andersen; Minna Nyström; Torben F Ørntoft
Journal:  Fam Cancer       Date:  2009-08-21       Impact factor: 2.375

4.  New RAB3GAP1 mutations in patients with Warburg Micro Syndrome from different ethnic backgrounds and a possible founder effect in the Danish.

Authors:  Deborah J Morris-Rosendahl; Reeval Segel; A Peter Born; Christoph Conrad; Bart Loeys; Susan Sklower Brooks; Laura Müller; Christine Zeschnigk; Christina Botti; Ron Rabinowitz; Gökhan Uyanik; Marc-Antoine Crocq; Uwe Kraus; Ingrid Degen; Fran Faes
Journal:  Eur J Hum Genet       Date:  2010-05-26       Impact factor: 4.246

5.  Splice site mutations in mismatch repair genes and risk of cancer in the general population.

Authors:  Mette Thomsen; Børge G Nordestgaard; Anne Tybjærg-Hansen; Stig E Bojesen
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

6.  A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Authors:  Iolanda Borelli; Guido C Casalis Cavalchini; Serena Del Peschio; Monica Micheletti; Tiziana Venesio; Ivana Sarotto; Anna Allavena; Luisa Delsedime; Marco A Barberis; Giorgia Mandrile; Paola Berchialla; Paola Ogliara; Cecilia Bracco; Barbara Pasini
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

7.  Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.

Authors:  Wenche Sjursen; Bjørn Ivar Haukanes; Eli Marie Grindedal; Harald Aarset; Astrid Stormorken; Lars F Engebretsen; Christoffer Jonsrud; Inga Bjørnevoll; Per Arne Andresen; Sarah Ariansen; Liss Anne S Lavik; Bodil Gilde; Inger Marie Bowitz-Lothe; Lovise Maehle; Pål Møller
Journal:  J Med Genet       Date:  2010-06-28       Impact factor: 6.318

8.  Sarcomas associated with hereditary nonpolyposis colorectal cancer: broad anatomical and morphological spectrum.

Authors:  Mef Nilbert; Christina Therkildsen; Anja Nissen; Måns Akerman; Inge Bernstein
Journal:  Fam Cancer       Date:  2009-01-08       Impact factor: 2.375

9.  An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.

Authors:  Yael Goldberg; Rinnat M Porat; Inbal Kedar; Chen Shochat; Daliah Galinsky; Tamar Hamburger; Ayala Hubert; Hana Strul; Revital Kariiv; Liat Ben-Avi; Moran Savion; Eli Pikarsky; Dvorah Abeliovich; Dani Bercovich; Israela Lerer; Tamar Peretz
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

10.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.